ArticleGenes & diseases2026

DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system.

Qinqin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.